Enzychem Lifesciences

[Available On-Demand]
Enzychem Lifesciences (KOSDAQ:183490) is developing novel small molecule therapeutics to target fundamental pathways in inflammation, patients with significant unmet needs in oncology, inflammatory, and severe respiratory diseases.
Ticker:
183490:KOSDAQ
Exchange:
KOSDAQ
Company Type:
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Korea - South Korea
Year Founded:
1999
Main Therapeutic Focus:
Lead Product in Development:
EC-18
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
1 in multiple indications including COVID-19, Oncology, NASH
Speaker
photo
Dr.
Enzychem Lifesciences